Both NNC0090-2746 (107) and tirzepatide (63) delivered clinically meaningful improvements in glycemic control and body weight reduction in their phase 1 trials
A study involving treatment up to 104 or 117 weeks in 134 patients with T2DM showed EX microspheres-nave patients experienced weight reductions of -2.7 kg (116)
Start free assessment
The promise of retatrutide is that a single molecule may coordinate several pathways at once
Thats why we prescribe medications like Liraglutide and Semaglutide GLP-1, injectable medications known for their efficacy in treating these conditions
Biopharma PEG supplies polyethylene glycol (PEG) derivatives, monodisperse PEGs, custom PEG derivative synthesis and PEGylation services worldwide, from R&D through GMP commercial quantities, for preclinical, clinical trials, and commercial products for pharma, biotech, medical devices, and diagnostics